I Bekersky

1.0k total citations
37 papers, 814 citations indexed

About

I Bekersky is a scholar working on Molecular Biology, Oncology and Pharmacology. According to data from OpenAlex, I Bekersky has authored 37 papers receiving a total of 814 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 8 papers in Oncology and 7 papers in Pharmacology. Recurrent topics in I Bekersky's work include Drug Transport and Resistance Mechanisms (6 papers), Renal Transplantation Outcomes and Treatments (5 papers) and Antifungal resistance and susceptibility (4 papers). I Bekersky is often cited by papers focused on Drug Transport and Resistance Mechanisms (6 papers), Renal Transplantation Outcomes and Treatments (5 papers) and Antifungal resistance and susceptibility (4 papers). I Bekersky collaborates with scholars based in United States, Japan and Switzerland. I Bekersky's co-authors include Donald N. Buell, Garry Boswell, Wayne A. Colburn, E.H. Mosbach, William G. Crouthamel, Abraham I. Louw, Dawna Dressler, Murray Oratz, Joseph Mongelli and Harold Boxenbaum and has published in prestigious journals such as Journal of Clinical Investigation, Neurology and Antimicrobial Agents and Chemotherapy.

In The Last Decade

I Bekersky

35 papers receiving 755 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
I Bekersky United States 17 185 156 149 128 127 37 814
Vijay Batra United States 17 216 1.2× 252 1.6× 204 1.4× 111 0.9× 253 2.0× 45 1.3k
Guillaume Hoizey France 16 110 0.6× 129 0.8× 109 0.7× 220 1.7× 63 0.5× 71 997
Nobuyuki Sugioka Japan 23 340 1.8× 130 0.8× 284 1.9× 204 1.6× 51 0.4× 87 1.8k
Kiumars Vadiei United States 16 118 0.6× 87 0.6× 90 0.6× 91 0.7× 40 0.3× 26 588
Helena Colom Spain 19 236 1.3× 117 0.8× 170 1.1× 241 1.9× 253 2.0× 86 1.2k
William Tracewell United States 17 295 1.6× 73 0.5× 120 0.8× 187 1.5× 146 1.1× 44 1.2k
Karl‐Friedrich Sewing Germany 16 151 0.8× 74 0.5× 140 0.9× 148 1.2× 43 0.3× 25 726
Manisha Ramaswamy Canada 19 331 1.8× 169 1.1× 304 2.0× 102 0.8× 72 0.6× 28 1.0k
Anton Pohanka Sweden 23 144 0.8× 108 0.7× 49 0.3× 153 1.2× 94 0.7× 51 1.2k
Belén Sádaba Spain 18 367 2.0× 136 0.9× 309 2.1× 53 0.4× 178 1.4× 59 1.4k

Countries citing papers authored by I Bekersky

Since Specialization
Citations

This map shows the geographic impact of I Bekersky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I Bekersky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I Bekersky more than expected).

Fields of papers citing papers by I Bekersky

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by I Bekersky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I Bekersky. The network helps show where I Bekersky may publish in the future.

Co-authorship network of co-authors of I Bekersky

This figure shows the co-authorship network connecting the top 25 collaborators of I Bekersky. A scholar is included among the top collaborators of I Bekersky based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with I Bekersky. I Bekersky is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tolbert, Dwain, Stuart Harris, I Bekersky, & Richard T Owen. (2012). Withdrawal-Related Adverse Events from Clinical Trials of Clobazam in Lennox-Gastaut Syndrome (LGS) (P06.106). Neurology. 78(Meeting Abstracts 1). P06.106–P06.106. 1 indexed citations
2.
Bekersky, I, Robert M. Fielding, Dawna Dressler, et al.. (2001). Pharmacokinetics, Excretion, and Mass Balance of <SUP>14</SUP>C after Administration of <SUP>14</SUP>C-Cholesterol-Labeled AmBisome to Healthy Volunteers. The Journal of Clinical Pharmacology. 41(9). 963–971. 27 indexed citations
3.
Bekersky, I, Justin C. Fay, John R. Wingard, et al.. (1998). Tacrolimus pharmacokinetics in BMT patients. Bone Marrow Transplantation. 21(1). 23–28. 39 indexed citations
4.
Bekersky, I, et al.. (1998). Demographic Considerations in Tacrolimus Pharmacokinetics. Transplantation Proceedings. 30(4). 1359–1364. 49 indexed citations
5.
Qi, Sihua, Dakang Xu, Don Vu, et al.. (1998). FK 506 and Rapamycin in Combination Are Not Antagonistic but Produce Extended Small Bowel Graft Survival in the Mouse. Transplantation Proceedings. 30(4). 1039–1041. 19 indexed citations
6.
Qi, Sihua, Da-Zhong Xu, William E. Fitzsimmons, et al.. (1998). Combined effect of rapamycin and FK 506 in prolongation of small bowel graft survival in the mouse. Transplantation Proceedings. 30(6). 2579–2581. 15 indexed citations
7.
Bekersky, I, et al.. (1998). Bioequivalence of a New Strength Tacrolimus Capsule Under Development. Transplantation Proceedings. 30(4). 1457–1459. 7 indexed citations
8.
Boswell, Garry, Donald N. Buell, & I Bekersky. (1998). AmBisome (Liposomal Amphotericin B): A Comparative Review. The Journal of Clinical Pharmacology. 38(7). 583–592. 174 indexed citations
9.
10.
11.
Bekersky, I, et al.. (1993). Disposition of a new antiinfective agent 1,3-di(4-imidazolino-2-methoxyphenoxy)propane in male rats.. Drug Metabolism and Disposition. 21(6). 1017–1021.
12.
Ferry, James J., et al.. (1988). Relative and Absolute Bioavailability of Prednisone and Prednisolone After Separate Oral and Intravenous Doses. The Journal of Clinical Pharmacology. 28(1). 81–87. 44 indexed citations
13.
14.
Williams, Thomas H., et al.. (1987). Metabolism of the anti-obesity agent, 4-amino-5-ethyl-3-thiophenecarboxylic acid methyl ester hydrochloride, in rats and dogs. Xenobiotica. 17(12). 1405–1414. 1 indexed citations
15.
16.
17.
Bekersky, I, et al.. (1980). Pharmacokinetics of saccharin in the rat. Renal clearance in vivo and in the isolated perfused kidney.. Drug Metabolism and Disposition. 8(2). 64–67. 13 indexed citations
18.
Bekersky, I, Lawrence M. Fishman, Samuel Kaplan, & Wayne A. Colburn. (1980). Renal clearance of salicylic acid and salicyluric acid in the rat and in the isolated perfused rat kidney.. Journal of Pharmacology and Experimental Therapeutics. 212(2). 309–314. 14 indexed citations
19.
20.
Louw, Abraham I., I Bekersky, & E.H. Mosbach. (1969). Improved synthesis of 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA). Journal of Lipid Research. 10(6). 683–686. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Vijay Batra Breakdown of academic impact, for papers by Guillaume Hoizey Breakdown of academic impact, for papers by Nobuyuki Sugioka Breakdown of academic impact, for papers by Kiumars Vadiei Breakdown of academic impact, for papers by Helena Colom Breakdown of academic impact, for papers by William Tracewell Breakdown of academic impact, for papers by Karl‐Friedrich Sewing Breakdown of academic impact, for papers by Manisha Ramaswamy Breakdown of academic impact, for papers by Anton Pohanka Breakdown of academic impact, for papers by Belén Sádaba
Rankless by CCL
2026